Hyderabad (Telangana) [India], July 12 (ANI): As over 3 crore people recover from COVID-19 in India, the incidence of post-COVID symptoms has noticeably increased.
New Delhi [India], July 2 (ANI): Antibiotic sales soared during the first COVID-19 wave in India last year, according to a study that suggests that drugs, especially azithromycin, were used to treat mild and moderate cases.
Washington DC [US], June 30 (ANI): The US House has passed a resolution recognizing the devastating impact of COVID-19 in India and expressing the sense of the House of Representatives to urgently facilitate assistance.
New Delhi [India], June 18 (ANI): As many as 62,480 new COVID-19 cases and 1,587 deaths were recorded in India in the last 24 hours, the Union Health Ministry informed on Friday.
New Delhi [India], June 3 (ANI/Oswaal Books): Amidst the 2nd wave of COVID-19 in India, Prime Minister Narendra Modi has finally communicated the much-awaited update on CBSE Class 12th Examination. In a recent meeting, the PM has cancelled the CBSE Class 12 board exam 2021.
New Delhi [India], June 3 (ANI): The Government of India has been making all efforts to augment the availability of vaccines (COVID-19) in India where through enhanced production in the country or through supply from abroad, the Ministry of External Affairs (MEA) spokesperson Arindam Bagchi
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisit
New Delhi [India], May 31 (ANI): BJP national president Jagat Prakash Nadda, Union Minister of State Anurag Thakur and Himachal Pradesh Chief Minister Jairam Thakur on Monday laid the foundation stone for two PSA oxygen plants at Hamirpur and Bilaspur.
Chennai (Tamil Nadu) [India], May 28 (ANI/NewsVoir): A new entrant into the treatment portfolio of COVID-19 in India is the cocktail formulation of Mono Clonal Antibodies (MCAb).
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
New Delhi [India], May 24 (ANI): Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose.
New Delhi [India], May 22 (ANI): The Central government has invited research and development (RandD) proposals from scientists for the invention of oxygen concentrators in order to curb the COVID-19 pandemic.